Trial Outcomes & Findings for Long QT Syndrome and Sleep Apnea (NCT NCT03678311)

NCT ID: NCT03678311

Last Updated: 2020-07-02

Results Overview

To examine the extent that OSA severity from overnight polysomnograph is associated with corrected QT interval (QTc) from daytime 12-lead ECG. The 24 hour continuous ECG is not available.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

9 participants

Primary outcome timeframe

The 12-lead ECG will be collected in the morning and the overnight polysomnography will be the duration of their sleep for the night.

Results posted on

2020-07-02

Participant Flow

Recruitment was delayed in starting. Start Date 3/13/2019, End Date 4/30/2019. Recruited people with a clinical diagnosis of QT Prolongation that were not on treatment for sleep disordered breathing, chronic sleep disorders, unstable medical conditions or rapid/uncontrolled heart rate (for safety reasons).

Baseline Study 9 completed, 4 qualified to continue and receive CPAP. Zero started the 3 month follow up (CPAP treatment). Because of contract issues CPAPs were not available. Study ended 4/30/2019.

Participant milestones

Participant milestones
Measure
Sleep Apnea Ahi > 5
If Sleep Apnea index is \> 5 and diagnosed with Long QT Syndrome Continuous Positive Airway Pressure (CPAP): If diagnosed with Long QT Syndrome and have Sleep Apnea index \>5 pauses per hour then given CPAP to wear for approximately 3 months.
Overall Study
STARTED
9
Overall Study
COMPLETED
9
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Long QT Syndrome and Sleep Apnea

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Sleep Apnea Ahi > 5
n=9 Participants
If Sleep Apnea index is \> 5 and diagnosed with Long QT Syndrome
Age, Continuous
52.5 years
STANDARD_DEVIATION 13.9 • n=5 Participants
Sex: Female, Male
Female
7 Participants
n=5 Participants
Sex: Female, Male
Male
2 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=5 Participants
Race (NIH/OMB)
White
7 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Body Mass Index (BMI)
31.8 kg/m^2
STANDARD_DEVIATION 4.8 • n=5 Participants
Apnea Hypopnea Index (AHI)
4.4 events per hour
n=5 Participants
Percent of Sleep Time with SaO2<90%
7 percent of sleep time
n=5 Participants
%SpO2
99.1 percent of oxygen saturation
STANDARD_DEVIATION 1.2 • n=5 Participants
STOPBANG
3.2 units on a scale
STANDARD_DEVIATION 1.7 • n=5 Participants
Epworth Sleepiness Scale
9.9 units on a scale
STANDARD_DEVIATION 3.1 • n=5 Participants
Patient Health Questionnaire-9
8.2 units on a scale
STANDARD_DEVIATION 6.9 • n=5 Participants

PRIMARY outcome

Timeframe: The 12-lead ECG will be collected in the morning and the overnight polysomnography will be the duration of their sleep for the night.

To examine the extent that OSA severity from overnight polysomnograph is associated with corrected QT interval (QTc) from daytime 12-lead ECG. The 24 hour continuous ECG is not available.

Outcome measures

Outcome measures
Measure
Sleep Apnea Ahi > 5
n=9 Participants
If Sleep Apnea index is \> 5 and diagnosed with Long QT Syndrome
QT Interval (Corrected) Baseline Visit
453.4 square root of seconds
Standard Deviation 28.7

PRIMARY outcome

Timeframe: The 12-lead ECG will be collected in the morning and the overnight polysomnography will be the duration of their sleep for the night. This will be collected at their follow up visit after wearing CPAP for 2-3 months.

Population: No patient started follow up (3 Month CPAP Treatment). Because of contract issues CPAPs were not available.

To examine the extent that OSA severity from overnight polysomnograph is associated with corrected QT interval (QTc) from daytime 12-lead ECG. The 24 hour continuous ECG is not available.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: After wearing CPAP for approximately 2-3 month the 12-lead ECG will be collected in the morning and the overnight polysomnography will be the duration of their sleep for the night.

Population: No patient started follow up (3 Month CPAP Treatment). Because of contract issues CPAPs were not available.

To investigate the change in LQTS after OSA treatment with 2-3 month continuous positive airway pressure (CPAP) on QTc collected from daytime 12-lead ECG in those with LQTS.

Outcome measures

Outcome data not reported

Adverse Events

Sleep Apnea Ahi >5

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Reena Mehra

Cleveland Clinic

Phone: 216-444-2165

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place